by editor | Aug 13, 2019 | Clinicians, Participants, Researchers
Impact of ASPREE trial on public health recognised We are pleased to share three Australian research accolades recently awarded to the ASPREE clinical trial for its significance to public health. ASPREE team acknowledged the contribution of participants,...
by editor | Feb 14, 2019 | Clinicians, Researchers
The ASPREE Aftermath: A Geriatric Perspective on the Role of Aspirin in Older Adults Thanks to permission from the American College of Cardiology, we are pleased to share this physician-penned article on the importance of the ASPREE study and the...
by editor | Sep 17, 2018 | Clinicians, Participants, Researchers
Daily low-dose aspirin doesn’t reduce heart-attack risk in healthy people For decades, doctors have been prescribing low-dose aspirin for healthy people over the age of 70. from shutterstock.com John McNeil, Monash University Taking low-dose aspirin daily...
by editor | Oct 20, 2016 | Clinicians, Participants, Researchers
Weekly Dose: aspirin, the pain and fever reliever that prevents heart attacks, strokes and maybe cancer Aspirin has an extraordinary history that involves many different discoveries around its many different effects. from shutterstock.com Andrew Tonkin, Monash...
by editor | Jun 3, 2016 | Clinicians, Researchers
Researchers cite ASPREE to inform aspirin guidelines in older adults International researchers anticipate findings from the ASPREE study will help fill a knowledge gap that led to the exclusion of older people from recent U.S. aspirin...
Recent Comments